Literature DB >> 22589557

Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages.

Lei Cai1, Zhen Wang, Jason M Meyer, Ailing Ji, Deneys R van der Westhuyzen.   

Abstract

Scavenger receptor BI (SR-BI), an HDL receptor, plays a key role in reverse cholesterol transport. In mice, disruption of SR-BI results in hypersensitivity to lipopolysaccharide (LPS) and bacteria-induced septic shock due to adrenal insufficiency and abnormal hepatic pathogen clearance. In this study, we identify an anti-inflammatory role of macrophage SR-BI. Using bone marrow transplantation, we report an enhanced pro-inflammatory response to LPS in wild-type (WT) mice receiving SR-BI-null compared with WT bone marrow cells and a reduced response in SR-BI-null mice receiving WT compared with SR-BI-null cells. Although significant, SR-BI deficiency limited to bone marrow-derived cells promoted a relatively modest enhancement of the inflammatory response to LPS in mice compared with the effect of whole-body SR-BI deletion. Consistent with earlier findings, SR-BI-null primary macrophages exhibited a greater inflammatory cytokine response to LPS than control macro phages. In addition, we showed that overexpression of SR-BI in J774 macrophages attenuated the inflammatory response to LPS. The LPS-induced cytokine expression in both WT and SR-BI-null macrophages was dependent not only on NFκB as previously reported but also on JNK and P38 cell signaling pathways. The increased inflammatory signaling in SR-BI-null cells was not related to alterations in cellular cholesterol content. We conclude that SR-BI plays an important function in regulating the macrophage inflammatory response to LPS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22589557      PMCID: PMC3540840          DOI: 10.1194/jlr.M023234

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

Review 1.  Management of sepsis.

Authors:  James A Russell
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 2.  Cooperation of Toll-like receptor signals in innate immune defence.

Authors:  Giorgio Trinchieri; Alan Sher
Journal:  Nat Rev Immunol       Date:  2007-03       Impact factor: 53.106

3.  Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells.

Authors:  Takao Kimura; Hideaki Tomura; Chihiro Mogi; Atsushi Kuwabara; Alatangaole Damirin; Tamotsu Ishizuka; Akihiro Sekiguchi; Mitsuteru Ishiwara; Doon-Soon Im; Koichi Sato; Masami Murakami; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2006-10-16       Impact factor: 5.157

4.  Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues.

Authors:  Thierry Huby; Chantal Doucet; Christiane Dachet; Betty Ouzilleau; Yukihiko Ueda; Veena Afzal; Edward Rubin; M John Chapman; Philippe Lesnik
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

5.  Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection.

Authors:  Jennifer A Philips; Eric J Rubin; Norbert Perrimon
Journal:  Science       Date:  2005-07-14       Impact factor: 47.728

6.  Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways.

Authors:  Yi Zhang; Ayesha M Ahmed; Nicole McFarlane; Christina Capone; Douglas R Boreham; Ray Truant; Suleiman A Igdoura; Bernardo L Trigatti
Journal:  J Lipid Res       Date:  2006-11-01       Impact factor: 5.922

7.  CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells.

Authors:  Tatyana G Vishnyakova; Roger Kurlander; Alexander V Bocharov; Irina N Baranova; Zhigang Chen; Mones S Abu-Asab; Maria Tsokos; Daniela Malide; Federica Basso; Alan Remaley; Gyorgy Csako; Thomas L Eggerman; Amy P Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

8.  Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages.

Authors:  Masahiro Koseki; Ken-Ichi Hirano; Daisaku Masuda; Chiaki Ikegami; Masaki Tanaka; Akemi Ota; Jose C Sandoval; Yumiko Nakagawa-Toyama; Satoshi B Sato; Toshihide Kobayashi; Yukiko Shimada; Yoshiko Ohno-Iwashita; Fumihiko Matsuura; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Lipid Res       Date:  2006-11-01       Impact factor: 5.922

9.  Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages.

Authors:  Kinga A Powers; Katalin Szászi; Rachel G Khadaroo; Patrick S Tawadros; John C Marshall; András Kapus; Ori D Rotstein
Journal:  J Exp Med       Date:  2006-07-17       Impact factor: 14.307

10.  Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain.

Authors:  Lynda M Stuart; Jiusheng Deng; Jessica M Silver; Kazue Takahashi; Anita A Tseng; Elizabeth J Hennessy; R Alan B Ezekowitz; Kathryn J Moore
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

View more
  22 in total

1.  Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-κB and MAPKs Signaling Pathway.

Authors:  Zhen Yu; Ling Tang; Lifen Chen; Jifang Li; Wanfu Wu; Changlin Hu
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

2.  Protocatechuic Acid Inhibits Inflammatory Responses in LPS-Stimulated BV2 Microglia via NF-κB and MAPKs Signaling Pathways.

Authors:  Huan-Yu Wang; Hong Wang; Jin-Huan Wang; Qiong Wang; Quan-Feng Ma; Yi-Yang Chen
Journal:  Neurochem Res       Date:  2015-07-02       Impact factor: 3.996

3.  Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.

Authors:  Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

4.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

Review 5.  SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis.

Authors:  MacRae F Linton; Huan Tao; Edward F Linton; Patricia G Yancey
Journal:  Trends Endocrinol Metab       Date:  2017-03-01       Impact factor: 12.015

6.  Macrophage SR-BI modulates autophagy via VPS34 complex and PPARα transcription of Tfeb in atherosclerosis.

Authors:  Huan Tao; Patricia G Yancey; John L Blakemore; Youmin Zhang; Lei Ding; W Gray Jerome; Jonathan D Brown; Kasey C Vickers; MacRae F Linton
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

7.  Pseudoginsenoside-F11 Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Neutrophil Infiltration and Accelerating Neutrophil Clearance.

Authors:  Pengwei Wang; Ying Hou; Wen Zhang; Haotian Zhang; Xiaohang Che; Yongfeng Gao; Yinglu Liu; Depeng Yang; Jingmin Wang; Rongwu Xiang; Mingyi Zhao; Jingyu Yang
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

8.  Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis.

Authors:  David P Hajjar; Katherine A Hajjar
Journal:  J Enzymol Metab       Date:  2016-05-31

9.  Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.

Authors:  Yan Song; Hongfeng Zhao; Jinyang Liu; Chao Fang; Renying Miao
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

Review 10.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.